Announcement of Director Retirement
The Board of Directors of Rua Bioscience Limited (NZX: RUA) advises that Mr Martin Smith has decided to retire as an Independent Non-Executive Director. Martin’s retirement will be effective at the conclusion of the 2022 Annual General Meeting scheduled for October 12, 2022.
Martin joined the Board of Directors in 2018 and is currently the Chair of the Nominations and Remunerations Committee.
Rua’s Chair Mr Trevor Burt, on behalf of the Board, expresses his sincere appreciation of Martin’s significant contribution to the company during his five-year tenure. Mr Burt said that ‘it is quite a career milestone for Martin to join our founders when the business was at the conceptual stage and to be a key part of the governance team who guided the business through to an NZX listing and readiness for export markets. We wish Martin all the best for his future.’
Martin Smith’s retirement is consistent with the Board’s succession plan and follows the recent appointment of Teresa Farac-Ciprian as an Independent Non-Executive Director. Teresa brings an exceptional background in commercialisation, innovation, marketing and business development – skills particularly relevant as the company nears export market entry.
ENDS
For more information please contact:
Kerry Donovan
Communications Manager, Rua Bioscience Ltd
[email protected]
+64 (0)21 128 7689
The S&P/NZX 50 Index rose 97.07 points, or 0.8%, to 12,447.68.
Fletcher Building subsidiary Iplex Australia to cover 80% of repair costs.
The bus operator's net loss widened from $8m to $17m in the year to March 31.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details